SCHEMBL206194

SCHEMBL206194

CCCCCOc1ccc(Nc2nc(-c3ccc4c(c3)NCCO4)cs2)cc1C(F)(F)F

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SYK P43405 1/20 0.46
MAPT P10636 9/20 0.44
SMN1; SMN2 Q16637 8/20 0.44
ALDH1A1 P00352 8/20 0.44
MEN1 O00255 7/20 0.44
KMT2A Q03164 7/20 0.44
RAB9A P51151 6/20 0.44
NPC1 O15118 5/20 0.44
TSHR P16473 1/20 0.44
HSD17B10 Q99714 1/20 0.44
GAA P10253 4/20 0.43
HTT P42858 2/20 0.43
MAPK1 P28482 1/20 0.43
CASP3 P42574 1/20 0.42
SENP8 Q96LD8 1/20 0.42
SENP7 Q9BQF6 1/20 0.42
SENP6 Q9GZR1 1/20 0.42
ALOX5 P09917 3/20 0.41
LMNA P02545 4/20 0.40
PTGS2 P35354 4/20 0.40

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL206604 0.88 SYK (0.45) SYKMAPTSMN1; SMN2ALDH1A1MEN1
SCHEMBL2698212 0.86 ALDH1A1 (0.61) SYKMAPTSMN1; SMN2ALDH1A1MEN1
SCHEMBL204308 0.86 ALDH1A1 (0.60) SYKMAPTSMN1; SMN2ALDH1A1MEN1
SCHEMBL206509 0.86 SMN1; SMN2 (0.57) MAPTSMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL207796 0.85 MAPT (0.56) MAPTSMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL207924 0.83 ALDH1A1 (0.45) SYKMAPTSMN1; SMN2ALDH1A1MEN1
SCHEMBL204744 0.82 MAPT (0.48) MAPTSMN1; SMN2ALDH1A1MEN1KMT2A
SCHEMBL206060 0.81 PTGES (0.46) MEN1KMT2ARAB9AALOX5S1PR1
SCHEMBL206916 0.81 ALOX5 (0.48) MAPTSMN1; SMN2MEN1KMT2ARAB9A
SCHEMBL250488 0.80 HSPD1 (0.51) MAPTSMN1; SMN2ALDH1A1MEN1KMT2A

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-8088806-B2 Thiazole compounds and methods of use ACHILLION PHARMACEUTICALS, INC. (US) 2012-01-03 US disclosed
US-20070004711-A1 Thiazole compounds and methods of use ACHILLION PHARMACEUTICALS, INC. 2007-01-04 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070004711-A1 Thiazole compounds and methods of use PIGS, CPT1A, SLC10A1 SYK 3675/4885MAPT 2207/4885SMN1; SMN2 3252/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.